TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Microbiotech/se AB
Closing information (x1000 EUR)
| Closing information | 2025/04 | 2024/04 | 2023/04 |
| Turnover |
290
|
264
|
235 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-1
|
21
|
2 |
| EBITDA |
-2
|
20
|
2 |
| Total assets |
208
|
195
|
198 |
| Current assets |
208
|
195
|
198 |
| Current liabilities |
25
|
23
|
35 |
| Equity capital |
176
|
165
|
154 |
| - share capital |
30
|
28
|
29 |
| Employees (average) |
4
|
4
|
3 |
Financial ratios
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Solvency |
84.6%
|
84.6%
|
77.8% |
| Turnover per employee |
72
|
66
|
78 |
| Profit as a percentage of turnover |
-0.3%
|
8.0%
|
0.9% |
| Return on assets (ROA) |
-0.5%
|
10.8%
|
1.0% |
| Current ratio |
832.0%
|
847.8%
|
565.7% |
| Return on equity (ROE) |
-0.6%
|
12.7%
|
1.3% |
| Change turnover |
7
|
38
|
-47 |
| Change turnover % |
2%
|
17%
|
-17% |
| Chg. No. of employees |
0
|
1
|
-1 |
| Chg. No. of employees % |
0%
|
33%
|
-25% |
Total value of public sale
| Fiscal year | 2025/04 | 2024/04 | 2023/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.